Citigroup’s Nanobiotix NBTX Stock Holding History

Citigroup’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$31	Buy	+1	New	+$39	﹤0.01%	5738
2026 Q2	–	Sell	-1	Closed	-$31	–	6076
2026 Q1	$31	Buy	+1	New	+$26	﹤0.01%	5677
2025 Q2	–	Sell	-241	Closed	-$853	–	5822
2025 Q1	$853	Hold	241	–	–	﹤0.01%	5373
2024 Q4	$692	Sell	241 -3,182	-93%	-$12.7K	﹤0.01%	5618
2024 Q3	$19.7K	Buy	+3,423	New	+$17.8K	﹤0.01%	5191
2024 Q1	–	Sell	-635	Closed	-$4.62K	–	5782
2023 Q4	$4.62K	Buy	+635	New	+$4.02K	﹤0.01%	5344

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

Citigroup's NBTX Position: Q3 2026 in Review

Citigroup opened a new position in Nanobiotix (NBTX) in Q3 2026: 1 share worth $31. The stake represents ﹤0.01% of the portfolio and ranks #5738 among its holdings. This is a return to the name: Citigroup previously reported a position in NBTX as recently as Q1 2026.

Citigroup first reported a position in NBTX in Q4 2023 and has held it in 6 quarters since. The position peaked at $19.7K in Q3 2024. 10 funds tracked by Wall St. Rank hold NBTX as of Q3 2026.

Citigroup held 1 share of Nanobiotix worth $31 as of Q3 2026.
Nanobiotix was a new Citigroup position in Q3 2026.
Nanobiotix made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5738 holding.
Citigroup first reported a position in Nanobiotix in Q4 2023 and has held it in 6 quarters since.
Citigroup's Nanobiotix position peaked at $19.7K in Q3 2024.
10 funds tracked by Wall St. Rank held Nanobiotix as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.